Related Experiment Video
Updated: May 24, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study
T Sonia Boender1, Kim C E Sigaloff, Joshua Kayiwa
1PharmAccess Foundation, P.O. Box 22700, 1100 DE, Amsterdam, The Netherlands.
Insights
Most children with HIV in Uganda present late for treatment. Factors like young age, caregiver unemployment, and lack of HIV prevention during birth contribute to delayed care, requiring multifaceted interventions.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Early diagnosis and treatment of HIV in children are crucial for better outcomes.
- Resource-limited settings often face challenges with late presentation of pediatric HIV cases.
Purpose of the Study:
- To identify factors associated with delayed treatment initiation in HIV-infected children in Uganda.
- To explore caregiver and health worker perspectives on barriers to timely HIV care.
Main Methods:
- Multilevel logistic regression analysis of clinical and demographic data from 306 children.
- Semistructured interviews with 49 caregivers and health workers to gather qualitative insights.
Main Results:
- 72% of children presented with late-stage HIV (WHO stages 3-4).
- Key risk factors included young age (<2 years), living without parents, caregiver unemployment, lack of perinatal HIV prophylaxis, and high transportation costs.
- Qualitative data highlighted inconsistent referrals, caregiver unawareness, fear, and stigma as additional barriers.
Conclusions:
- Late presentation of pediatric HIV in Uganda is a significant issue driven by complex health system and individual-level factors.
- Addressing these multifactorial determinants is essential for improving early diagnosis and treatment initiation for children living with HIV.
Abstract:
Although the advantages of early infant HIV diagnosis and treatment initiation are well established, children often present late to HIV programs in resource-limited settings. We aimed to assess factors related to the timing of treatment initiation among HIV-infected children attending three clinical sites in Uganda. Clinical and demographic determinants associated with early disease (WHO clinical stages 1-2) or late disease (stages 3-4) stage at presentation were assessed using multilevel logistic regression. Additionally, semistructured interviews with caregivers and health workers were conducted to qualitatively explore determinants of late disease stage at presentation. Of 306 children initiating first-line regimens, 72% presented late. Risk factors for late presentation were age below 2 years old (OR 2.83, P = 0.014), living without parents (OR 3.93, P = 0.002), unemployment of the caregiver (OR 4.26, P = 0.001), lack of perinatal HIV prophylaxis (OR 5.66, P = 0.028), and high transportation costs to the clinic (OR 2.51, P = 0.072). Forty-nine interviews were conducted, confirming the identified risk factors and additionally pointing to inconsistent referral from perinatal care, caregivers' unawareness of HIV symptoms, fear, and stigma as important barriers. The problem of late disease at presentation requires a multifactorial approach, addressing both health system and individual-level factors.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Sexually Transmitted Infections

